Literature DB >> 9549444

Interrupting the sympathetic outflow in causalgia and reflex sympathetic dystrophy.

G D Schott.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9549444      PMCID： PMC1112764          DOI： 10.1136/bmj.316.7134.792

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  11 in total

Review 1.  Reflex sympathetic dystrophy syndrome: a review.

Authors:  F Kozin
Journal:  Clin Exp Rheumatol       Date:  1992 Jul-Aug       Impact factor: 4.473

2.  Management of causalgia after peripheral nerve injury.

Authors:  F L Girgis; C B Parry
Journal:  Int Disabil Stud       Date:  1989 Jan-Mar

Review 3.  Reflex sympathetic dystrophy.

Authors:  E Paice
Journal:  BMJ       Date:  1995-06-24

Review 4.  An unsympathetic view of pain.

Authors:  G D Schott
Journal:  Lancet       Date:  1995-03-11       Impact factor: 79.321

5.  Painful peripheral states and sympathetic blocks.

Authors:  L Loh; P W Nathan
Journal:  J Neurol Neurosurg Psychiatry       Date:  1978-07       Impact factor: 10.154

Review 6.  Visceral afferents: their contribution to 'sympathetic dependent' pain.

Authors:  G D Schott
Journal:  Brain       Date:  1994-04       Impact factor: 13.501

7.  Systemic alpha-adrenergic blockade with phentolamine: a diagnostic test for sympathetically maintained pain.

Authors:  S N Raja; R D Treede; K D Davis; J N Campbell
Journal:  Anesthesiology       Date:  1991-04       Impact factor: 7.892

8.  'Sympathetically maintained pain.' I. Phentolamine block questions the concept.

Authors:  R J Verdugo; J L Ochoa
Journal:  Neurology       Date:  1994-06       Impact factor: 9.910

9.  Intravenous regional guanethidine in the treatment of reflex sympathetic dystrophy/causalgia: a randomized, double-blind study. Guanethidine Study Group.

Authors:  S Ramamurthy; J Hoffman
Journal:  Anesth Analg       Date:  1995-10       Impact factor: 5.108

Review 10.  Intravenous regional sympathetic blockade for pain relief in reflex sympathetic dystrophy: a systematic review and a randomized, double-blind crossover study.

Authors:  A R Jadad; D Carroll; C J Glynn; H J McQuay
Journal:  J Pain Symptom Manage       Date:  1995-01       Impact factor: 3.612
View more
  8 in total

Review 1.  Reflex sympathetic dystrophy.

Authors:  G D Schott
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-09       Impact factor: 10.154

2.  Interrupting the sympathetic outflow in causalgia and reflex sympathetic dystrophy. Terminology is outdated-1994 taxonomy should be used.

Authors:  L Allan
Journal:  BMJ       Date:  1998-09-12

Review 3.  Controversies surrounding reflex sympathetic dystrophy: a review article.

Authors:  R P Pawl
Journal:  Curr Rev Pain       Date:  2000

4.  Endoscopic thoracic sympathectomy for posttraumatic complex regional pain syndrome.

Authors:  K Demey; S Nijs; W Coosemans; H Decaluwé; G Decker; P De Leyn; D Van Raemdonck; A Sermon; P Broos; T Lerut; P Nafteux
Journal:  Eur J Trauma Emerg Surg       Date:  2011-02-22       Impact factor: 3.693

5.  Physical therapy management of complex regional pain syndrome I in a 14-year-old patient using strain counterstrain: a case report.

Authors:  Cristiana Kahl Collins
Journal:  J Man Manip Ther       Date:  2007

Review 6.  [Recent trends in understanding and therapy of complex regional pain syndromes].

Authors:  G Wasner; J Schattschneider; A Binder; D Siebrecht; C Maier; R Baron
Journal:  Anaesthesist       Date:  2003-10       Impact factor: 1.041

7.  Lumbar Sympathetic Block with Botulinum Toxin Type A and Type B for the Complex Regional Pain Syndrome.

Authors:  Yongki Lee; Chul Joong Lee; Eunjoo Choi; Pyung Bok Lee; Ho-Jin Lee; Francis Sahngun Nahm
Journal:  Toxins (Basel)       Date:  2018-04-19       Impact factor: 4.546

Review 8.  Molecular Aspects of Regional Pain Syndrome.

Authors:  Manuela Baronio; Hajra Sadia; Stefano Paolacci; Domenico Prestamburgo; Danilo Miotti; Vittorio A Guardamagna; Giuseppe Natalini; Stephanie G B Sullivan; Matteo Bertelli
Journal:  Pain Res Manag       Date:  2020-04-11       Impact factor: 3.037
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.